EMEA-001126-PIP01-10-M03 - paediatric investigation plan

Deferiprone

Key facts

• Active substance:
  Deferiprone
• Therapeutic area:
  Haematology-Hemostaseology
• Decision number:
  P/0189/2019
• PIP number:
  EMEA-001126-PIP01-10-M03
• Pharmaceutical form(s):
  Oral solution
• Condition(s) / indication(s):
  Treatment of chronic iron overload
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  15/05/2019
• Compliance check done:
  No

Decision

P/0189/2019: EMA decision of 15 May 2019 on the acceptance of a modification of an agreed paediatric investigation plan for deferiprone (EMEA-001126-PIP01-10-M03)

Adopted Reference Number: EMA/216915/2019